Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet DAWNZERA 80mg solution for injection in pre-filled pen
- Product code:
- W72063001
- Quantity:
- 1
- Indicated for:
- prevention of recurrent hereditary angioedema attacks in adults and adolescents aged 12 years and older
- Route of administration:
- injectable
- Substance:
- donidalorsen (antisense oligonucleotide reducing plasma prekallikrein production)
- ATC
- B06AC09 — Blood and blood forming organs | Other hematological agents | Other hematological agents | Drugs used in hereditary angioedema
Precautions:
General warning
Read the package leaflet before use.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Pediatric warning
Use in children only as recommended in the leaflet or by a doctor.
Genetic test recommended
A genetic test may be needed before treatment.
General data about DAWNZERA 80mg
- Substance:
- donidalorsen
- Date of latest medicines list:
- 01-08-2026
- Product code:
- W72063001
- Concentration:
- 80mg
- Pharmaceutical form:
- solution for injection in pre-filled pen
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.